financetom
Business
financetom
/
Business
/
Exchange Income Corp. Announcing Renewal Of Normal Course Issuer Bid For Common Shares And Debentures
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exchange Income Corp. Announcing Renewal Of Normal Course Issuer Bid For Common Shares And Debentures
Mar 14, 2024 2:36 PM

05:17 PM EDT, 03/14/2024 (MT Newswires) -- Exchange Income Corporation ( EIFZF ) Thursday announced that the Toronto Stock Exchange has approved the renewal of EIC's normal course issuer bid for the common shares of EIC and certain series of debentures of EIC.

Pursuant to the NCIB, EIC can purchase up to an aggregate of 4.4 million Common Shares; $7.9 million principal amount of 7 year 5.35% convertible unsecured subordinated debentures of EIC (Debentures (June 2018)); $8.6 million principal amount of 7 year 5.75% convertible unsecured subordinated debentures of EIC (Debentures (March 2019)); $14.3 million principal amount of 7 year 5.25% convertible unsecured subordinated debentures of EIC (Debentures (July 2021)); and $11.5 million principal amount of 7 year 5.25% convertible unsecured subordinated debentures of EIC (Debentures (December 2021)), representing 10% of the public float of each series of Securities as at March 5, 2024.

Purchases of Securities pursuant the NCIB may be made through the facilities of the TSX commencing on March 19, 2024 and ending on March 18, 2025, or an earlier date in the event that EIC purchases the maximum number of each of the Securities available under the NCIB. EIC will pay the market price at the time of acquisition for any Securities purchased through the facilities of the TSX.

All Securities acquired directly by EIC under the NCIB will be cancelled.

As at March 5, 2024, there were 47.2 million Common Shares, $79.7 million principal amount of Debentures (June 2018), $86 million principal amount of Debentures (March 2019), $143.7 million principal amount of Debentures (July 2021), and $115 million principal amount of Debentures (December 2021) issued and outstanding.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: BlackRock Asks US FDIC to Extend Deadline on Oversight Agreement
Update: BlackRock Asks US FDIC to Extend Deadline on Oversight Agreement
Jan 10, 2025
10:12 AM EST, 01/10/2025 (MT Newswires) -- (Updates with the US FDIC's response in the fourth paragraph and latest stock movement in the fifth paragraph.) BlackRock ( BLK ) has made a request to the US Federal Deposit Insurance Corporation to extend a deadline for a new oversight agreement relating to its stakes in FDIC-regulated banks, media reports said Friday....
What's Going On With Shell Shares On Friday?
What's Going On With Shell Shares On Friday?
Jan 10, 2025
Shell PLC ( SHEL ) shares are trading higher on Friday after the company’s subsidiary, Shell Offshore Inc., started production at the Whale floating production facility in the Gulf of Mexico. The Whale project utilizes a streamlined, cost-effective design modeled after the Vito platform, which launched operations in early 2023. The development is a joint venture between Shell Offshore, holding...
Nvidia Unveils Generative AI Workflow for Digital Shopping Assistants
Nvidia Unveils Generative AI Workflow for Digital Shopping Assistants
Jan 10, 2025
10:20 AM EST, 01/10/2025 (MT Newswires) -- Nvidia ( NVDA ) said Friday it has created a blueprint for a generative AI workflow designed to support online and in-store shopping. Using the Nvidia AI Enterprise and Omniverse platforms, developers will be able to create AI-powered digital assistants with features including multimodal and multi-query capabilities, reasoning capabilities for humanlike interactions, and...
Pacira Biosciences Reports Preliminary 2024 Revenue Rose, Outlines Five-Year Plan
Pacira Biosciences Reports Preliminary 2024 Revenue Rose, Outlines Five-Year Plan
Jan 10, 2025
10:14 AM EST, 01/10/2025 (MT Newswires) -- Pacira Biosciences ( PCRX ) reported preliminary 2024 revenue Friday of $701 million, up from $675 million a year earlier. Analysts polled by FactSet expect $695.1 million. The company also outlined a five-year strategy to expand its focus on musculoskeletal pain and related areas, aiming for growth by 2030. The plan, called 5x30,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved